RxDoctor Payments Data

Nagaraj Kikkeri, MD

Interventional Pain Medicine · Mesquite, TXNPI 1396745311

Payments from drug & device makers

$2,538in general payments, 2019–2025

Across 70 payments — averaging $36.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$722
  • Abbott$596
  • Si-bone, Inc.$362
  • Biotronik NRO, Inc.$227
  • Vertos Medical, Inc.$164
  • Bioventus LLC$80
  • plus $386 from 11 others
$109in research payments, 2019–2025

Across 1 payment — averaging $108.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$109

What the payments were for

  • Food & beverage$2,288100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,538 in reported general payments places this provider in the 30th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$159,049
Medicare patients
316
Services billed
1,542

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,155$40,621
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen157$7,413
Fentanyl14$2,249
Gabapentin135$1,798
Lidocaine21$1,593
Tizanidine Hcl60$1,558
Baclofen93$1,353
Oxycodone Hcl70$1,039
Celecoxib34$524
Morphine Sulfate11$360
Acetaminophen-CodeineAcetaminophen With Codeine19$359
Cyclobenzaprine Hcl20$319
Pregabalin14$223
Duloxetine Hcl15$198
Cephalexin23$173

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Mesquite

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →